Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

16.7%

11 terminated/withdrawn out of 66 trials

Success Rate

79.6%

-6.9% vs industry average

Late-Stage Pipeline

17%

11 trials in Phase 3/4

Results Transparency

63%

27 of 43 completed trials have results

Key Signals

5 recruiting27 with results8 terminated

Enrollment Performance

Analytics

N/A
38(61.3%)
Phase 2
9(14.5%)
Phase 4
8(12.9%)
Phase 1
3(4.8%)
Phase 3
3(4.8%)
Early Phase 1
1(1.6%)
62Total
N/A(38)
Phase 2(9)
Phase 4(8)
Phase 1(3)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (66)

Showing 20 of 66 trials
NCT05606289Not ApplicableCompleted

Trial of Crisis Intervention Team (CIT) Mental Health Training for Police Officers

Role: collaborator

NCT05999240Phase 2Recruiting

Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder

Role: collaborator

NCT07469384Not ApplicableRecruiting

Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways

Role: collaborator

NCT04898699Early Phase 1Completed

IPrEP Men's Study: Expanding the Reach of Prevention for Men in Kisumu, Kenya

Role: collaborator

NCT05587530Not ApplicableTerminated

Zero Suicide Implementation in Outpatient Mental Health Clinics

Role: collaborator

NCT04067661Not ApplicableTerminated

A Couples-based Intervention for Transgender Women and Their Partners

Role: collaborator

NCT03135886Not ApplicableRecruiting

Project I Test: Implementing HIV Testing in Opioid Treatment Programs

Role: collaborator

NCT03718936Recruiting

ADNP Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing ADNP-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.

Role: collaborator

NCT03718923Recruiting

FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.

Role: collaborator

NCT05645042Not ApplicableTerminated

Transcendental Meditation in Veterans and First Responders With PTSD

Role: lead

NCT04596891Not ApplicableCompleted

Acceptance and Mindfulness Based Exposure Therapy for Survivors of Cardiac Arrest

Role: lead

NCT03068325Not ApplicableCompleted

Trauma-Focused Equine-Assisted Therapy (TF-EAT) for Veterans With PTSD

Role: lead

NCT06019247Not ApplicableEnrolling By Invitation

Individual Placement and Support Mexico

Role: collaborator

NCT05818228Not ApplicableCompleted

Reducing Self-Stigma Among Individuals with History of Childhood Maltreatment

Role: lead

NCT05057624Not ApplicableWithdrawn

Gaze-Contingent Music Reward Treatment for PTSD

Role: lead

NCT06159075Not ApplicableCompleted

Reducing Self-Stigma Among Individuals with History of Childhood Maltreatment: a Cross-Cultural Lens

Role: lead

NCT03891667Phase 1Completed

Disulfiram: A Test of Symptom Reduction Among Patients With Previously Treated Lyme Disease

Role: lead

NCT05826132Not ApplicableCompleted

Digital Mental Health Care for COVID-19 High-Risk Populations - Phase 2

Role: lead

NCT04129580Not ApplicableCompleted

reSET-O RCT (Randomized Controlled Trial)

Role: collaborator

NCT04386291Not ApplicableCompleted

Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19

Role: lead